Skip to main content

Table 2 Genotypes and PAVM

From: A retrospective cohort study on European Reference Network for Rare Vascular Diseases 5 outcome measures for Hereditary Haemorrhagic Telangiectasia in Denmark

Genotype Number of patients (percentage of the total population n = 180) Patients with PAVM identified (percentage of genotype subgroup)
HHT1 89 (49%) 38 (42.7%)
HHT2 67 (37%) 12 (17.9%)
JP-HHT 15 (8%) 5 (33%)
Clinical HHT 9 (5%) 2 (22.5%)